Выйти из депрессии. Проверенная программа преодоления эмоционального расстройства

45

Madhukar H. Trivedi, A. John Rush, Stephen R. Wisniewski, et al., «Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice,» American Journal of Psychiatry 163, 28–40 (2006).

46

Jules Angst, «Major Depression in 1998: Are We Providing Optimal Therapy?» Journal of Clinical Psychiatry 60, 5–9 (1999, Suppl. 6).

47

P. W. Lavori, M. B. Keller, T. I. Mueller, and W. Scheftner, «Recurrence After Recovery in Unipolar MDD: An Observational Follow-Up Study of Clinical Predictors and Somatic Treatment as a Mediating Factor,» International Journal of Methods in Psychiatric Research 4, 211–229 (1994).

48

Angst, «Major Depression.»

49

Ronald C. Kessler, Katherine A. McGonagle, Shanyang Zhao, Christopher B. Nelson, et al., «Lifetime and 12-month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results from the National Comorbidity Study,» Archives of General Psychiatry 51, 8-19 (1994); Ronald C. Kessler, Christopher B. Nelson, Katherine A. McGonagle, J. Liu, et al., «Comorbidity of DSM-III-R Major Depressive Disorder in the General Population: Results from the U.S. National Comorbidity Study,» British Journal of Psychiatry 18, 17–30 (1996, Suppl. 30).

50

Вероятно, автор имеет в виду тревожно-депрессивное расстройство. – (Прим. науч. ред.)

51

Maurizio Fava, A. John Rush, Jonathan E. Alpert, et al., «Difference in Treatment Outcome in Outpatients with Anxious versus Nonanxious Depression: A STAR*D Report,» American Journal of Psychiatry 165:3, 342–351 (2008).

52

Gavin Andrews. «Comorbidity and the General Neurotic Syndrome,» British Journal of Psychiatry 168, 76–84 (1996, Suppl. 30).

53

Это рассмотрено в: Richard O’Connor, Active Treatment of Depression (New York: Norton, 2001).

54

Charles B. Nemeroff, «Comorbidity of Mood and Anxiety Disorders: Thе Rule, Not the Exception?» American Journal of Psychiatry 159:1, 3–4 (2002).